Page 156 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 156
185. Diefenbach MA, Dorsey J, Uzzo RG, et al. 196. Xu J, Dailey RK, Eggly S, et al. Men’s
Decision-making strategies for patients with perspectives on selecting their prostate
localized prostate cancer. Semin Urol Oncol cancer treatment. Journal of the National
2002;20:55-62. Medical Association 2011;103:468-478.
186. Zietman AL, Thakral H, Wilson L, et al. 197. Lin GA, Aaronson DS, Knight SJ, et al.
Conservative management of prostate cancer Patient decision aids for prostate cancer
in the prostate specific antigen era: the treatment: a systematic review of the
incidence and time course of subsequent literature. CA Cancer J Clin 2009;59:379-
therapy. J Urol 2001;166:1702-1706. 390.
187. Holmboe ES, Concato J. Treatment 198. Jang TL, Bekelman JE, Liu Y, et al.
decisions for localized prostate cancer: Physician visits prior to treatment for
asking men what's important. J Gen Intern clinically localized prostate cancer. Arch
Med 2000;15:694-701. Intern Med 2010;170:440-450.
188. Fowler Jr FJ, McNaughton CM, Albertsen 199. Shavers VL, Brown M, Klabunde CN, et al.
PC, et al. Comparison of recommendations Race/ethnicity and the intensity of medical
by urologists and radiation oncologists for monitoring under ‘watchful waiting’ for
treatment of clinically localized prostate prostate cancer. Med Care 2004;42:239-250.
cancer. JAMA 2000;283:3217-3222.
200. D’Amico AV, Whittington R, Malkowicz
189. Chapple A, Ziebland S, Herxheimer A, et al. SB, et al. Biochemical outcome after radical
Is ‘watchful waiting’ a real choice for men prostatectomy, external beam radiation
with prostate cancer? A qualitative study. therapy, or interstitial radiation therapy for
BJU Int 2002;90:257-264. clinically localized prostate cancer. JAMA
1998;280:969-974.
190. Demark-Wahnefried W, Schildkraut JM,
Iselin CE, et al. Treatment options, 201. Shariat SF, Karakiewicz PI, Roehrborn CG,
selection, and satisfaction among African et al. An updated catalog of prostate cancer
American and white men with prostate predictive tools. Cancer 2008;113:3075-
carcinoma in North Carolina. Cancer 3099.
1998;83:320-330.
202. Jadad AR, Moore RA, Carroll D, et al.
191. Berry DL, Ellis WJ, Woods NF, et al. Assessing the quality of reports of
Treatment decision-making by men with randomized clinical trials: is blinding
localized prostate cancer: the influence of necessary? Control Clin Trials 1996;17:1-
personal factors. Urol Oncol 2003;21:93- 12.
100.
203. Auvinen A, Hakama M, la-Opas M, et al. A
192. Steginga SK, Occhipinti S, Gardiner RA, et randomized trial of choice of treatment in
al. Making decisions about treatment for prostate cancer: the effect of intervention on
localized prostate cancer. BJU Int the treatment chosen. BJU Int 2004;93:52-
2002;89:255-260. 56.
193. Crawford ED, Bennett CL, Stone NN, et al. 204. Davison BJ, Goldenberg SL, Wiens KP, et
Comparison of perspectives on prostate al. Comparing a generic and individualized
cancer: analyses of survey data. Urology information decision support intervention
1997;50:366-372. for men newly diagnosed with localized
prostate cancer. Cancer Nurs 2007;30:E7-
194. O’Rourke ME. Narrowing the options: the 15.
process of deciding on prostate cancer
treatment. Cancer Invest 1999;17:349-359. 205. Davison BJ, Degner LF. Empowerment of
men newly diagnosed with prostate cancer.
195. Anandadas CN, Clarke NW, Davidson SE, Cancer Nurs 1997;20:187-196.
et al. Early prostate cancer--which treatment
do men prefer and why? BJU International 206. Elwyn G, O’Connor A, Stacey D, et al.
2011;107:1762-1768. Developing a quality criteria framework for
patient decision aids: online international
Delphi consensus process. BMJ
2006;333:417.
102
